Why Ovarian Cancer Stays Hidden Until It's Too Late
A cancer survivor reveals how ovarian cancer evades detection, why screening fails, and what patients need to know about symptoms doctors miss.
A cancer survivor reveals how ovarian cancer evades detection, why screening fails, and what patients need to know about symptoms doctors miss.
When Kari Neumeyer attended an ovarian cancer awareness walk a decade before her diagnosis, she took home pamphlets listing the telltale signs: bloating, fatigue, back pain, changes in bowel habits. The problem? Every single one of these symptoms could mean something else entirely.
Ovarian cancer affects 1 in 78 people with ovaries across all ages, yet we have no reliable screening tool. There’s no ovarian version of a mammogram. A Pap smear won’t catch it. Blood tests like CA-125 produce too many false positives and false negatives to be useful as a screening method. The result is a cancer that often goes undetected until it has already advanced to stages where it becomes nearly impossible to treat.
Neumeyer’s own diagnosis came by accident. A dermatologist removed what she thought was a harmless growth from her navel, the size of a pencil eraser. The biopsy revealed ovarian cancer that had already spread through her abdomen, with tumors the size of small citrus fruits in each ovary. She had been experiencing back pain six months earlier but attributed it to lifting her elderly dog. Sharp chest pains in recent years? She convinced herself it was heartburn from eating too much chocolate.
Those symptoms existed. She just didn’t connect them to her ovaries, and neither did the medical system designed to catch disease early.
In online support groups, Neumeyer discovered countless stories of delayed diagnosis. Some patients discovered their cancer while pregnant or struggling with infertility. Others were sent home with diagnoses of irritable bowel syndrome, heartburn, or menopause. Too many were told they were overweight, dramatic, or simply making too big a deal out of nothing.
We also misdiagnose ourselves. We avoid emergency rooms because we’re embarrassed, because we assume symptoms will pass, because waiting hours in an ER seems worse than the discomfort we’re experiencing. A rational calculation that often proves tragically wrong.
When Neumeyer finally met her gynecologic oncologist, she received both grim and cautiously hopeful news: “Ovarian cancer isn’t curable, but it is treatable.” Surgery removed her ovaries, fallopian tubes, uterus, cervix, and 10 inches of colon that had been perforated by a tumor. Initial chemotherapy didn’t work, a common problem with her rare subtype called low-grade serous ovarian cancer.
Now, over a year cancer-free, Neumeyer understands ovarian cancer as a chronic illness. Recurrence remains likely. But she also knows something crucial that many patients never learn: early screening doesn’t improve ovarian cancer survival rates. Not because we shouldn’t try to catch it early, but because we currently have no effective early detection method and no cure.
When friends ask Neumeyer what they should do, her gynecologic oncologist’s advice is simple: tell your doctor about your symptoms and ask directly, “Do you think this could have something to do with my ovaries?” Don’t demand unnecessary tests. Don’t self-diagnose via internet research. Just listen to your body and push for answers when something feels wrong.
But individual vigilance can only do so much. What we actually need is what we don’t have: research that leads to a cure, and a screening tool that works reliably.
Ovarian cancer is sneaky, yes. But it’s also a problem we’ve allowed to persist through underfunding, lack of awareness, and a medical system that still struggles to take women’s health seriously. Until we invest in real research and real solutions, asking patients to catch an invisible disease will never be enough.
Originally published on HuffPost